Mechanisms of Disease: adipocytokines and visceral adipose tissue—emerging role in nonalcoholic fatty liver disease

被引:0
|
作者
Andreas Schäffler
Jürgen Schölmerich
Christa Büchler
机构
[1] University of Regensburg,doctor Department of Internal Medicine I
[2] University of Regensburg,Director Department of Internal Medicine I
[3] University of Regensburg,molecular biologist in the Department of Internal Medicine I
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Accumulation of visceral adipose tissue and the subsequent alteration in the secretion of adipocytokines could contribute to hypertension, impaired fibrinolysis and insulin resistance. This review discusses the role of visceral adipose tissue and the adipocytokines in nonalcoholic fatty liver disease.
引用
收藏
页码:273 / 280
页数:7
相关论文
共 50 条
  • [1] Mechanisms of Disease:: adipocytokines and visceral adipose tissue -: emerging role in nonalcoholic fatty liver disease
    Schäffler, A
    Schölmerich, J
    Büchler, C
    [J]. NATURE CLINICAL PRACTICE GASTROENTEROLOGY & HEPATOLOGY, 2005, 2 (06): : 273 - 280
  • [2] Mechanisms of Disease: adipocytokines and visceral adipose tissue—emerging role in intestinal and mesenteric diseases
    Andreas Schäffler
    Jürgen Schölmerich
    Christa Büchler
    [J]. Nature Clinical Practice Gastroenterology & Hepatology, 2005, 2 : 103 - 111
  • [3] Visceral adipose tissue visfatin in nonalcoholic fatty liver disease
    Gaddipati, Radhika
    Mitnala, Sasikala
    Padaki, Nagarajarao
    Mukherjee, Rathindra Mohan
    Sekaran, Anuradha
    Jayaraj-Mansard, Magnus
    Rabella, Pradeep
    Rao-Guduru, Venkat
    Reddy-Duvvuru, Nageshwar
    [J]. ANNALS OF HEPATOLOGY, 2010, 9 (03) : 266 - 270
  • [4] Mechanisms of disease:: adipocytokines and visceral adipose tissue-emerging role in intestinal and mesenteric diseases
    Schäffler, A
    Schölmerich, J
    Büchler, C
    [J]. NATURE CLINICAL PRACTICE GASTROENTEROLOGY & HEPATOLOGY, 2005, 2 (02): : 103 - 111
  • [5] Metabolic liver disease of obesity and role of adipose tissue in the pathogenesis of nonalcoholic fatty liver disease
    Kamran Qureshi
    Gary A Abrams
    [J]. World Journal of Gastroenterology, 2007, (26) : 3540 - 3553
  • [6] Metabolic liver disease of obesity and role of adipose tissue in the pathogenesis of nonalcoholic fatty liver disease
    Qureshi, Kamran
    Abrams, Gary A.
    [J]. WORLD JOURNAL OF GASTROENTEROLOGY, 2007, 13 (26) : 3540 - 3553
  • [7] Visceral adipose tissue and risk of nonalcoholic fatty liver disease: A Mendelian randomization study
    Tao, Min
    Zhou, Guanghong
    Liu, Jing
    He, Miao
    Wang, Cong
    Luo, Xie
    Zhang, Lili
    [J]. CLINICAL ENDOCRINOLOGY, 2023, 99 (04) : 370 - 377
  • [8] Reply to: "Liver-adipose tissue crosstalk in nonalcoholic fatty liver disease: the emerging role of remnant cholesterol"
    Lee, Eunyoung
    Korf, Hannelie
    Vidal-Puig, Antonio
    [J]. JOURNAL OF HEPATOLOGY, 2024, 80 (03) : e112 - e114
  • [9] Nonalcoholic fatty liver disease: emerging mechanisms and consequences
    Turkish, Aaron R.
    [J]. CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE, 2008, 11 (02): : 128 - 133
  • [10] Visceral adipose tissue quality was associated with nonalcoholic fatty liver disease, independent of its quantity
    Igarashi, Yusuke
    Tanaka, Muhei
    Okada, Hiroshi
    Hashimoto, Yoshitaka
    Kumagai, Muneaki
    Yamaoka, Miyoko
    Nishimura, Hiromi
    Fukui, Michiaki
    [J]. NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, 2022, 32 (04) : 973 - 980